Director, Global Submission Programs & Cross-Functional Leadership

Kite Pharma; San Francisco (CA); On-site; USD 226,000 - 293,000; Full time

Benefits offered by this job

Benefits package

Discretionary bonus

Job summary

Kite Pharma, a leader in cancer immunotherapies, seeks a Director-level Submission Project Manager to drive regulatory submissions and cross-functional execution. You will align clinical data, regulatory strategy, and operations to ensure timely, high-quality filings across BLAs, sBLAs, and global submissions.

Preferred candidates bring deep experience in oncology or cell-therapy development, exceptional leadership, and a track record of delivering complex regulatory programs in a matrixed

Qualifications

• Doctorate with extensive pharma/biotech experience (6+ years).
• Master's degree with 10+ years experience.
• Bachelor's degree with 12+ years experience.
• Experience leading regulatory submissions (BLAs, sBLAs, NDAs) and cross-functional programs preferred.

Responsibilities

• Lead end-to-end regulatory submission strategy and governance for major filings (BLAs, sBLAs, NDAs).
• Coordinate cross-functional teams across Development, Biostatistics, Regulatory, and Quality to ensure timely submissions.
• Develop integrated submission plans with milestones, dependencies, risks, and execution priorities.
• Mentor Global Project Management talent and drive continuous improvement across submission practices.

Skills

Cross-functional leadership

Strategic thinking

Regulatory submission leadership

Executive communication

Education

Doctorate in Pharmaceutical/Biotech

Master's degree

Bachelor's degree

Job description

Kite Pharma, a leader in cancer immunotherapies, seeks a Director-level Submission Project Manager to drive regulatory submissions and cross-functional execution. You will align clinical data, regulatory strategy, and operations to ensure timely, high-quality filings across BLAs, sBLAs, and global submissions.

Preferred candidates bring deep experience in oncology or cell-therapy development, exceptional leadership, and a track record of delivering complex regulatory programs in a matrixed